(8.1, 8.2) Pediatric Use: Safety and effectiveness in pediatric patients below the age of 11 years have not been established
All Vitamin IV therapies are done under medical doctor supervision.
Preclinical studies show that GLP-1 receptor activation reduces amyloid-beta and tau pathology in laboratory models, and observational data link GLP-1 therapy to lower dementia risk in diabetes patients
It includes online consultations, home delivery of medication when available, 24/7 messaging with providers, nutritional guidance, and access to a private community for peer support
The EXSCEL trial (Bethel et al., 2020) and LEADER trial (Marso et al., 2016) investigated the effect of exenatide and liraglutide, respectively, on microvascular and cardiovascular outcomes in patients with type 2 diabetes